InfoBionic.Ai and HBox.ai Ink Cardiology Care Partnership

The AI-driven technology platforms from both companies will create the 'Cardiology Clinic of the Future.'

By: Michael Barbella

Managing Editor

InfoBionic.ai and HBox.ai are teaming up to develop a cardiovascular care solution fit for the “Cardiology Clinic of the Future.” 

HBox.ai, known for its “Virtual Clinic in a Clinic” model, provides an AI-driven technology platform and services enabling cardiology practices to offer virtual care services to patients while generating new recurring revenue streams. InfoBionic.Ai delivers artificial intelligence (AI)-enabled cardiac telemetry solutions to cardiology practices nationwide. InfoBionic.Ai’s approach consolidates the virtual telemetry service line into a highly efficient and clinically superior tool, according to the company. With flexible business models, partners can seamlessly integrate their solution in a way that best fits their existing infrastructure and workflow. 

“At InfoBionic.Ai, we believe that partnering with HBox.ai will deliver unmatched value to cardiology practices nationwide. Our combined AI capabilities will enable us to offer healthcare providers a unique, comprehensive solution, empowering them to deliver the highest quality care for their patients. This partnership embodies our shared vision of revolutionizing cardiovascular care with the ‘Cardiology Clinic of the Future.'” InfoBionic.ai CEO Stuart Long said. 

This partnership enables both companies to create the cardiovascular care industry’s first integrated AI-Driven Virtual Consult, RPM, Chronic Care and diagnostic cardiac monitoring solution, empowering the creation of the “Cardiology Clinic of the Future.” By combining their deep and wide datasets with their AI expertise, HBox.ai and InfoBionic.Ai aim to create an end-to-end view of a cardiac patient’s condition, providing healthcare providers with unparalleled clinical insights.  

HBox.ai and InfoBionic.Ai are elevating cardiovascular care by providing new and more effective tools for doctors to diagnose and predict risk. Beyond clinical care, this partnership will deploy AI in all aspects of care delivery including patient engagement and bringing operational efficiency to cardiology outpatient centers. Ultimately, the goal is reduced hospitalizations and improved outcomes for patients.

“We see tremendous synergy between HBox.ai and Infobionic.ai that will enable us to create a one-of-a-kind cardiology platform benefiting both patients and providers. HBox.ai is excited to collaborate with InfoBionic.ai to move beyond our current go-to-market partnership and develop a fully integrated, AI-driven model that promises innovation in both product and business models for cardiovascular outpatient centers.” HBox.ai CEO Banuprasad Dhanakoti stated.

HBox.ai develops AI-driven technology platforms, offering cardiology practices a unique “Virtual Clinic in a Clinic” model. This model enables practices to deliver virtual care services while creating new recurring revenue streams. 

InfoBionic.Ai claims its digital technology has transformed the efficiency and economics of cardiac remote patient monitoring. The company’s vision for its U.S. Food and Drug Administration-cleared third-generation platform, the MoMe ARC, is to remove the roadblocks hindering virtual and remote diagnosis and decision-making. The Massachusetts-based team of entrepreneurs has had successful careers in healthcare, IT, medical devices, and mobile technology, and brings specific expertise in remote monitoring and cardiology. 

 

 

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters